Journals / Medicine Science / 2022 / Cilt: 11 - Sayı: 2

Etiological evaluation and the role of plasma exchange treatment in trombotic microangiopathies: A retrospective analysis from Eastern Anatolia

Pages
762–765
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The primary treatment in HELLP syndrome was termination of pregnancy, it was observed in our study that TPE was effective in TTP, HELLP syndrome and snake bites and treatment should be started without delay

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim is this study was to make the etiological classification of patients diagnosed with TMA in our region and to statistically evaluate the effect of therapeutic plasma exchange, which we use in treatment, on laboratory recovery and mortality.
📊
Key Findings & Data:In our study, between 2009-2017, 85 patients diagnosed with TMA in our center evaluated retrospectively.
💡
Conclusion & Impact:The primary treatment in HELLP syndrome was termination of pregnancy, it was observed in our study that TPE was effective in TTP, HELLP syndrome and snake bites and treatment should be started without delay
🔬Design:Research Article
📍Scope:2009-2017 Verileri
⚙️Variables:Domain Parameters

Abstract

The aim is this study was to make the etiological classification of patients diagnosed with TMA in our region and to statistically evaluate the effect of therapeutic plasma exchange, which we use in treatment, on laboratory recovery and mortality. In our study, between 2009-2017, 85 patients diagnosed with TMA in our center evaluated retrospectively. Thirty- one (36.5%) of our patients were followed up with HELLP, 23 with thrombotic thrombocytopenic purpura (TTP) (27.1%), 20 (23.5%) snake bites, and 11 (12.9%) with atypical hemolytic uremic syndrome (aHUS). TPE treatment was performed in all patients. TPE treatment was found effective in patients with HELLP syndrome, TTP and snake bite and statistically significant improvement was obtained in laboratory parameters (p0.05). Mortality rates were found 9.7%, 21.7%, 27.3%, and 0% in patients with HELLP Syndrome, TTP, aHUS, and snake bite, respectively. The primary treatment in HELLP syndrome was termination of pregnancy, it was observed in our study that TPE was effective in TTP, HELLP syndrome and snake bites and treatment should be started without delay

🔖

Cite This Article

ERKURT, M. A., KAYA, E., HİDAYET, E., KUKU, İ., UYSAL, A., BERBER, İ., BİÇİM, S., KAYA, A., SARICI, A., ÖZGÜL, M. (2022). Etiological evaluation and the role of plasma exchange treatment in trombotic microangiopathies: A retrospective analysis from Eastern Anatolia. Medicine Science, Cilt: 11 - Sayı: 2, 762–765. https://ajindex.com/articles/579562

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Tsai HM. Untying the knot of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome. Am J Med 2013;126:200-9
  2. George JN. How I treat Patients With Thrombotic Thrombocytopenic purpura: Blood 2010;116:4060-9
  3. Burns ER, Lou Y, Pathak A. Morphologic diagnosis of thrombotic thrombocytopenic purpura. Am J Hematol 2004;75:18-21
  4. Copelovitch L, Kaplan BS. The thrombotic microangiopathies. Pediatr Nephrol 2008;23:1761-7 5. Arnold DM, Patriquin CJ, Nazy I. Thrombotic microangiopathies: a general approach to diagnosis and management. CMAJ 2017;189:153-9 6. Scully M, Hunt BJ, Benjamin S, et al. Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 2012; 158: 323-35
  5. Moake JL. Thrombotic microangiopathies. N Engl J Med 2002;347:589-600
  6. Tekgündüz E, Yılmaz E, Erkurt MA et all. A multicenter experience of thrombotic microangiopathies in Turkey: The Turkish Hematology Research and Education Group (ThREG)-TMA01 study. Transfus Apher Sci 2018:57;27-30
  7. Huestis DW, Bove JR, Busch S. Practical Blood Transfusion. 3rd ed. Boston: Little, Brown and Company. 1981:315-72
  8. Korkmaz S, Medeni SS, Demirkan F et all. The Turkish Experience With Therapeutic Plasma Exchange: A National Survey. Transfus Apher Sci 2019:58;287-92
  9. Martin JN Jr, Blake PG, Lowy SL, et al. Pregnancy complicated by preeclampsiaeclampsia with syndrome of hemolysis, elevated liver enzymes and low platelet count: How rapid is postpartum recovery? Obstet Gynecol 1990;76:737
  10. Sibai BM, Ramadan MK, Usta I, et al. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLPsyndrome). Am J Obstet Gynecol 1993;169:1000-6
  11. Eser B, Guven M, UnalA et all. The Role of Plasma Exchange in HELLP Syndrome. Clin Appl Thromb Hemost 2005;11:211–17
  12. Erkurt MA, Berber I, Berktas HB. A life-saving therapy in Class I HELLP syndrome: Therapeutic plasma exchange. Transfus Apher Sci. 2015;52:194-8
  13. Zheng X,Chung D,Takayama TK, et al. Structure of von Willenrand factor cleaving protease (ADAMTS 13), a metalloprotelnase involved in trombotic thrombocytopenic purpura. J Biol Chem 2001;276:41059-63
  14. Page EE, Kremer Hovinga JA, Terrell DR, et al. Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015. Blood Adv 2017;1:590-600.botic thrombocytopenic purpura/hemolytic uremi